OFFICE OF THE GENERAL COUNSEL
Nevada State Board of Medical Examiners
‘9600 Gateway Drive
Reno, Nevada 89521
(775) 688-2559

v1
a

BEFORE THE BOARD OF MEDICAL EXAMINERS

OF THE STATE OF NEVADA

In the Matter of Charges and Complaint Case No. 25-41463-1
Against: FILED
AKINDELE EMMANUEL KOLADE, M. OCT 09 205
Respondent. negReeness

Met INE!

By: :

COMPLAINT

The Investigative Committee! (IC) of the Nevada State Board of Medical Examiners
(Board), by and through Alexander J. Hinman, Deputy General Counsel and attomey for the IC,
having a reasonable basis to believe that Akindele Emmanuel Kolade, M.D., (Respondent) violated
the provisions of Nevada Revised Statutes (NRS) Chapter 630 and Nevada Administrative Code
(NAC) Chapter 630 (collectively, the Medical Practice Act), hereby issues its Complaint, stating the
IC's charges and allegations as follows

1. Respondent was at all times relative to this Complaint a medical doctor holding an
active license to practice medicine in the State of Nevada (License No. 15135). Respondent was
originally licensed by the Board on January 21, 2014, with a specialty in psychiatry.

2. Respondent, at all times relative to this Complaint, held an active Nevada
Controlled Substance Registration, Certificate No. CS21917, issued by the Nevada State Board of|
Pharmacy (Pharmacy Board).

3. On July 23, 2021, the Pharmacy Board filed a Notice of Intended Action and
Accusation (Accusation) against three (3) physicians, which included Respondent.
uy
ui

' The Investigative Committee of the Nevada State Board of Medical Examiners, at the time this formal
Complaint was authorized for filing, was composed of Board members Bret W. Frey, M.D., Col. Eric D Wade, and
Carl N. Williams, Jr., M.D.

lof

‘3600 Gateway Drive
Reno, Nevada 89521
(775) 688-2559

OFFICE OF THE GENERAL COUNSEL.
[Nevada State Board of Medical Examiners

i

4. In the Accusation filed by the Pharmacy Board, seven (7) causes of action were
alleged against Respondent. One (1) of the causes of action was Violation of State Law which
included multiple violations of NRS Chapters 639 and 453. See Exhibit 1.

5. On October 15, 2021, the Pharmacy Board entered into a Stipulation and Order
(Order) with Respondent.

6. In the Order, Respondent admitted that “evidence exists, and that Board staff}
prosecuting this case could present such evidence at an administrative hearing to establish a
factual basis for the violations alleged in the Accusation.” The violations included pre-signing
prescriptions and filling prescriptions while engaged in overseas travel. See Exhibit 2.

7. The Pharmacy Board formally disciplined Responded when the board suspended
his license to prescribe controlled substances, with the suspension stayed and Respondent placed
on probation for a period of two (2) years. During Respondent’s probationary period, he was
ordered to pay a five thousand dollar ($5,000) fine and reimburse a portion of the Pharmacy
Board’s costs in prosecution of the case.

COUNT
NRS 630.306(1)(b)(3) - Violation of Statutes and Regulations of the
Nevada State Board of Pharmacy

8 _Alll of the allegations in the above paragraphs are hereby incorporated by reference
as though fully set forth herein.

9. Respondent is a practitioner as defined by NRS 639.0125(1), as a physician, who
holds a license to practice medicine in the State of Nevada.

10. NRS 630.306(1)(b)(3) provides that engaging in conduct that violates a provision
of chapter 639 of NRS, or a regulation adopted by the Pharmacy Board pursuant thereto, that is
applicable to a licensee who is a practitioner, as defined in NRS 639.0125, is grounds for initiating
discipline against a licensee.

ll. The Pharmacy Board adopted NAC 454.060, which sets forth requirements for
written prescriptions for dangerous drugs. NAC 454.060 incorporates and includes the

prescription requirements of NRS 454.223. In part, NRS 454.223(2)(a) provides:

2o0fS

OFFICE OF THE GENERAL COUNSEL

‘Nevada State Board of Medical Examiners

9600 Gateway Drive

Reno, Nevada 89521

(775) 688-2559

Cea an

ut

2. A written prescription must contain: (a) The name of the
practitioner, the signature of the practitioner if the prescription was
not transmitted orally and the address of the practitioner if not
immediately available to the pharmacist;

12, According to the Accusation by the Pharmacy Board, Respondent violated
NRS 453.226(1), NRS 453.232, NRS 453.321(1)(a), NRS 453.331(1)(f) and (h), NRS 453.381(1),
NRS 453.401(1)(a), NRS 639.100(1), NRS 639.235(1), NRS 639.281(1), NRS 639.2813(1), and
NAC 453.440(1)(c) when Respondent was out of the country on multiple occasions and issued
prescriptions for dangerous drugs to patients of which he did not have a bona fide
physiciar/patient relationship with which is inconsistent with the public interest.

13. By reason of the foregoing, Respondent is subject to discipline by the Board as
provided in NRS 630.352.

COUNTIL
NRS 630.306(1)(p) - Unsafe or Unprofessional Conduct

14, All of the allegations in the above paragraphs are hereby incorporated as if fully set
forth herein.

15. Engaging in any act that is unsafe or unprofessional conduct in accordance with
regulations adopted by the Board is grounds for disciplinary action against a licensee pursuant to
NRS 630.306(1)(p).

16. As demonstrated by, but not limited to, the above-outlined facts, Respondent wrote
prescriptions to patients in a manner that deviated from professional standards, therefore
Respondent’s conduct was unsafe and unprofessional.

17. By reason of the foregoing, Respondent is subject to discipline by the Board as
provided in NRS 630.352.

WHEREFORE, the IC prays:

1. That the Board give Respondent notice of the charges herein against him and give
him notice that he may file an answer to the Complaint herein as set forth in
NRS 630.339(2) within twenty (20) days of service of the Complaint;
uy

3 ofS

OFFICE OF THE GENERAL COUNSEL

24,
a

2. That the Board set a time and place for a formal hearing after holding an Early
Case Conference pursuant to NRS 630.339(3);

3. That the Board determine what sanctions to impose if it determines there has been
a violation or violations of the Medical Practice Act committed by Respondent;

4. That the Board award fees and costs for the investigation and prosecution of this
case as outlined in NRS 622.400;

5. That the Board make, issue and serve on Respondent its findings of fact,
conclusions of law and order, in writing, that includes the sanctions imposed; and

6. That the Board take such other and further action as may be just and proper in these
premises.

DATED this Ea day of October, 2025.

INVESTIGATIVE COMMITTEE OF THE
NEVADA STATE BOARD OF MEDICAL EXAMINERS

ALEXANDER J. HINMAN
Deputy General Counsel

9600 Gateway Drive

Reno, NV 89521

Tel: (775) 688-2559

Email: ahinman@medboard.nv.gov

Attorney for the Investigative Committee

4o0f5

9600 Gateway Deve
eno, Nevada 89521
(075) 688-2559

OFFICE OF THE GENERAL COUNSEL
[Nevada State Board of Medical Examiners


13,
15,


VERIFICATION
STATE OF NEVADA

COUNTY OF WASHOE)
Bret W. Frey, M.D., having been duly sworn, hereby deposes and states under penalty of

perjury that he is the Chairman of the Investigative Committee of the Nevada State Board of
Medical Examiners that authorized the Complaint against the Respondent herein, that he has read
the foregoing Complaint; and that based upon information discovered in the course of the
investigation into a complaint against Respondent, he believes that the allegations and charges in
the foregoing Complaint against Respondent are true, accurate and correct.

DATED this’ day of October, 2025.

INVESTIGATIVE COMMITTEE OF THE.
NEVADA STATE BOARD OF MEDICAL EXAMINERS

By:

BRET WA REY, M.D.
Chairman of the Investigative Committee

Sof 5

EXHIBIT 1

EXHIBIT 1
FILED
JUL 23 2021

NEVADA STATE BOARD
(OF PHARMACY,
BEFORE THE NEVADA STATE BOARD OF PHARMACY
NEVADA STATE BOARD OF PHARMACY, Case Nos. 19-237-CS-A-S
19-237-CS-B-S
Petitioner, 19-237-CS-C-S

v.

AKINDELE E. KOLADE, MD,
Certificate of Registration No. CS21917, NOTICE OF INTENDED ACTION

AND ACCUSATION
JEAN-MARIE SWAINE, APRN,
Certificate of Registration No. CS24065, and

NNENNA A. OLUBAJO, APRN,
Certificate of Re; ition No. CS27850,

Respondents.

J. David Wuest, in his official capacity as Executive Secretary of the Nevada State Board
of Pharmacy, makes the following that will serve as both a notice of intended action under NRS

233B.127(3) and as an accusation under NRS 622A.300(1) and NRS 639.241.

1. ‘The Nevada State Board of Pharmacy (Board) has jurisdiction over this matter
because at the ume of the events alleged herein, Respondent Akindele E, Kolade, MD (Kolade),
held a controlled substance registration, Certificate of Registration No CS21917; Respondent
Jean-Marie Swaine, APRN (Swaine), held a controlled substance registration, Certificate of
Registration No. CS24065; and Respondent Nnenna A. Olubajo, APRN (Olubajo), held a
controlled substance registration, Certificate of Registration No, CS27850, all issued by the
Board
FACTUAL ALLEGATIONS
2. Kolade unlawfully sssued thirteen (13) prescriptions for controlled substances

while engaged in overseas travel, to patients with whom he did not have a bona fide therapeutic


relationship, by pre-signing prescriptions and/or providing a signature stamp to Swaine and

Olubajo. Prescriber records and prescriptions document that Swaine and Olubajo unlawfully
issued these controlled substance prescriptions under Kolade’s name and credentials while
Kolade was traveling outside of the U.S. n April 2018, October 2018, and February 2019,

3. Olubajo prescribed controlled substances and dangerous drugs prior to being
registered to do so. Prescriber records and prescriptions document a total of eight (8) controlled

substance prescriptions w

fen prior to October 17, 2018, when Olubiyo was issued Certificate
of Registration No CS27850.
APPLICABLE LAW

4. tis unlawful for a practitioner to prescribe a controlled substance except as
authorized by law. 21 U.S.C. § 822(a)(2), 21 US.C § 823(f); 2! CFR § 1306.03-§ 1306.05;
NRS 453.226(1), NRS 453.232; NRS 453 321(1)(a), NRS 453 377, NRS 453.381; NRS.

639. 100(1); NRS 639.235(1); NAC 453 440.

SA prescription for a controlled substance may be issued only for a legitimate
medical purpose and in the usual course of his or her professional practice by an individual
practitioner who holds a DEA registration and is authorized to prescribe controlled substances by
the jurisdiction in which he 1s licensed to practice his profession, 21 U.S.C. § 822(a)(2); 21
USS.C. § 823(f); 21 CFR § 1306.03(a)(1); 21 CFR § 1306 04(ay; NRS 453.381(1).

6 Anadvanced practice registered nurse may only prescribe controlled substances
with authorization from both the Board and the State Board of Nursing. NRS 639.2351; NAC
639.854,

7. Itisa felony offense to falsify a prescription for a controlled substance. 21 U.S C.

§ 841(a), 21 U.S.C. § 842(a); NRS 453 331(1) (0) and (h),

8. Falsely representing onesell as « practitioner entitled to write prescriptions in
this state 1s a felony offense. 21 U.S.C § 841(a); 21 U.S.C. § $42(a); NRS 639 281(1); NRS
453 331(1)(c), NRS 639.2813(1).

9. Conspiring to violate the Controlled Substances Act is a felony offense. 21
US.C. § 846, NRS 453.401 (I)(a).

10. Performing or in any way being a party to any fraudulent or deceitful practice or
transaction constitutes unprofessional conduct or conduct contrary to the public interest pursuant
to NAC 639.945(1 )(h) and is grounds for suspension or revocation of any license or registration
Issued by the Board. NRS 639.210(4).

11 Performing any duties ay the holder of a controlled substance registration in an
incompetent, unskillful or negligent manner constitutes unprofessional conduct or conduct
contrary to the public interest pursuant to NAC 639.945(1)(1) and 1s grounds for suspension or
revocation of any license or registration 1ssued by the Board, NRS 639.210(4).

12. Performing any act, task or operation for which licensure is required without the
required registration constitutes unprofessional conduct or conduct contrary to the public interest
pursuant to NAC 639.945(1)(k) and is grounds for suspension or revocation of any license issued
by the Board. NRS 639 210(4)

13. Prescribing a drug as a prescribing practitioner to a patent with whom the
Practitioner does not have a bona fide therapeutic relationship constitutes unprofessional conduct
or conduct contrary to the public interest pursuant to NAC 639.945(1}(0) and is grounds for
suspension or revocation of any license or registration issued by the Board. NRS 639.210(4)

14, Violating any provision of the Federal Food, Drug and Cosmetic Act or any other
federal law or regulation relating to prescription drugs is grounds for suspension or revocation of

any license or registration issued by the Board. NRS 639.210(11)

15. Violating, attempting to violate, assisting or abetting in the violation of or
conspiring to violate any law or regulation relating to drugs is grounds for suspension or
revocation of any license or registration issued by the Board. NRS 639 210(12).

16. The Board may suspend or revoke a registration issued pursuant to NRS 453 231
to prescribe or otherwise dispense a controlled substance upon a finding that the registrant has
committed an act that would render registration inconsistent with the public interest. NRS

453.236(1)(d) and NRS 453.241(1).

FIRST CAUSE OF ACTION

Violations of Federal Controlled Substances Act

17. By 1ssuing controlled substance prescriptions under Kolade’s name and
credentials while Kolade was engaged in overseas travel, to patients with whom he did not have
a bona fide therapeutic relationship, as alleged herein, Kolade, Swaine and Olubajo violated,
‘attempted to violate, assisted or abetted in the violation of or conspired (0 violate 21 U.S.C §
822(a)(2), 21 U.S.C § 823(f), 21 U.S.C § 841 (a), 21 U S.C. § 842(a), 21 U.S.C § 846, 21 CFR
§ 1306.03(a)(1), 21 CFR § 1306.04(a) and/or 21 CFR § 1306.05, and are subject to discipline
pursuant to NRS 453.236(1) and NRS 639.210(11).

SECOND CAUSE OF ACTION
Violations of State Law

18. By issuing controlled substance prescriptions under Kolade’s name and

credentials while Kolade was engaged in overseas travel, to pauents with whom he did not have

a bona fide therapeutic relationship, as alleged herein, Kolade, Swaine and Olubayo violated,

attempted to violate, assisted or abetted in the violation of or conspired to violate NRS
453.226(1), NRS 453.232, NRS 453 321(1)(a), NRS 453.331(1) (f) and (h), NRS 453.381(1),
NRS 453 401 (1)(a), NRS 639.100(1), NRS 639 235(1), NRS 639.2811), NRS 639.2813(1)
and/or NAC 453.440(1)(c), and are subject to discipline pursuant to NRS 453 236(1) and NRS
639.210(12).

Unprofessional Conduct — dulent/Deceitful Practice/Transa
Incompetent, Unshillful or Negligent Performance of Duties

19. By tssuing controlled substance prescriptions under Kolade’s name and
credentials while Kolade was engaged in overseas travel, to patients with whom he did not have
bona fide therapeutic relationship, as alleged herein, Kolade, Swaine and Olubajo were party 10
a fraudulent or deceitful practice or transaction, performed their duties as the holders of
Controlled substance registrations in an incompetent, unskillful or negligent manner, engaged in
unprofessional conduct and conduct contrary to the public interest in violation of NAC

639.945(1)(h) and (i), and are subject to disciphne pursuant to NRS 453.236(1) and NRS
639.210(4),

FOURTH CAUSE OF ACTION
Unprofessional Conduct ~ Prescribing Without Bona Fide Therapeutic Relationship
(Respondent Akindele E. Kolade, MD)

20 By prescribing controlled substances for patients with whom he had not
established a bona fide therapeutic relationship, before he had examined the patients and without

his direct supervision, and for whom he had neither diagnosed or determined that a controlled

substance was medically necess

s alleged herein, Kolade engaged in unprofessional conduct
and conduct contrary to the public interest sn violation of NAC 639.945(1)(0), and is subject to

discipline pursuant to NRS 453.236(1) and NRS 639.210(4).

FIFTH CAUSE OF ACTION
Violations of Federal and State Law for Unlicensed Prescribing
(Respondent Nnenna A Olubajo, APRN)

21 By prescribing controlled substances prior to being registered to do so, as alleged
herein, Olubayo violated, attempted to violate, assisted or abetted in the violation of or conspired
(o violate 21 U.S.C. § 822(a)(2), 21 U.S.C. § 823(f), 21 USC. § 841(a), 21 U.S.C. § 842(a), 21
US.C. § 846, 21 CFR § 1306.03(a)(1), 21 CFR § 1306.04(a), NRS 453.226(1), NRS 453.232,
NRS 453.321(1)(a), NRS 453.331(1)(c), (and (h), NRS 453.381(1), NRS 453.401(I)(a), NRS

639.100(1), NRS 63

1. ARS 639 281(1), NRS 639 2813(1), NAC
453.440(1)(c) and/or NAC 639.854, and 15 subject to discipline pursuant to NRS 639.210(11)
and (12).
SIXTH CAUSE OF ACTION
Unprofessional Conduct - Unlicensed Prescribing/ Party to a Fraudulent/Deceitful
Practice/Transaction/ Incompetent, Unskillful or Negligent Performance of Duties
(Respondent Nnenna A. Olubajo, APRN)

22. By prescribing controlled substances prior to being licensed to do so, as alleged
herein, Olubayo was a party to a fraudulent or deceitful practice or transaction, performed her
duties as the holder of a controlled substance registration in an incompetent, unskillful or
negligent manner, engaged in unprofessional conduct and conduct contrary to the public interest

in violation of NAC 639.945(1)(h), (i) and (k), and 1s subject to discipline pursuant to NRS
453.236(1) and NRS 639.210(4).

SEVENTH CAUSE OF ACTION
Commission of Acts that Render Registration Inconsistent with the Public Interest

23. By their actions as alleged herein, Kolade, Swaine and Olubajo have committed
acts that render their registrations to prescribe controlled substances inconsistent with the public

interest pursuant to NRS 453.231, and are subject to discipline pursuant to NRS 453.236(1)(d)
and NRS 453.241(1).

WHEREFORE it is requested that the Nevada State Board of Pharmacy take appropriate

disciplinary action with respect to the certificates of registration of these Respondents.

ie
DATED this _23" day of July, 2021. LY,

J. bavi Woh, Kf. Executive Secretary
Nev. fte Board of Pharmacy

You have the

to show the Nevada State Board of Pharmacy that your conduct, as
alleged above, complies with all lawful requirements, NRS 233B.127(3). You have the right to
a hearing before the Board to answer the Notice of Intended Action and Accusation and present
evidence and argument on all issues involved, either personally or through counsel. NRS
233B.121; NRS 233B.127(3), NRS 622A.300(1) and (3), NRS 639.241 To do so, you must
complete and file two (2) copies of the Answer and Notice of Defense served herewith, to be
received by the Board’s Reno office located at 985 Damonte Ranch Parkway ~ Suite 206, Reno,
Nevada 89521, within twenty (20) days of your receipt of this Notice of Intended Action and
Accusation, NRS 622A 320; NRS 639.243. Your failure to umely file an Answer and Notice of
Defense constitutes an admission of the charges and waiver of the right to a hearing. NRS
639.244. If you fail to appear at the hearing and the Board finds that you were given sufficient
legal notice of the hearing, the Board may accept the allegations as true and may proceed to

consider the case and render a decision. NRS 622A.350.

EXHIBIT 2

EXHIBIT 2
FILED

euty

OCT 15 2021
evansrarg gon
BEFORE THE NEVADA STATE BOARD OF PHARMAC
NEVADA STATE BOARD OF PHARMACY, Case Nos. 19-237-CS-A-S
19-237-CS-B-S
19-237-CS-C-S
v.
AKINDELE E. KOLADE, MD,
Certificate of Registration No. CS21917, STIPULATION AND ORDER
(Respondent Kolade ONLY)

JEAN-MARIE SWAINE, APRN,
Certificate of Registration No. CS24065, and

NNENNA A. OLUBAJO, APRN,
Certificate of Registration No. CS27850,

Respondents.

Brett Kandt, General Counsel for Petitioner the Nevada State Board of Pharmacy
(Board), and Respondent Akindele E. Kolade, MD, Certificate of Registration No. CS21917, by
and through counsel, Maria Nutile, Esq., and Bridget Kelly, Esq., HEREBY STIPULATE AND
AGREE THAT:

1. ‘The Board has jurisdiction over Respondent and this matter.

2. Onor about July 23, 2021, Respondent was served with the Notice of Intended
Action and Accusation (Accusation) on file in this matter together with the Statement to
Respondent and Notice of Hearing.

3. Onor about August 16, 2021, Respondent filed an Answer and Notice of Defense
to the Accusation,

4, Respondent is fully aware of the right to seek the advice of counsel in this matter
and obtained the advice of counsel prior to entering into this Stipulation.

5. Respondent is aware of the right to a hearing on the matters alleged in the

Accusation, the right to reconsideration, the right to appeal and any and all other rights which

may be accorded to him pursuant to NRS Chapter 233B (Nevada Administrative Procedure Act),
NRS Chapter 622A (Administrative Procedure Before Certain Regulatory Bodies), and NRS
Chapter 639 (Nevada Pharmacy Act).

6. Conditioned on the acceptance of this Stipulation by the Board, and with the
exception of the right to challenge any determination that Respondent has failed to comply with
the provisions of this Stipulation, Respondent hereby freely and voluntarily waives his rights to a
hearing, reconsideration, appeal and any and all other rights related to this action that may be
accorded to him by NRS Chapter 233B (Nevada Administrative Procedure Act), NRS Chapter
622A (Administrative Procedure Before Certain Regulatory Bodies), and NRS Chapter 639
(Nevada Pharmacy Act).

7, Respondent admits that evidence exists, and that Board staff prosecuting this case
could present such evidence at an administrative hearing, to establish a factual basis for the
violations alleged in the Accusation, to wit:

A. Respondent pre-signed prescriptions and/or provided a signature stamp to
Respondents Jean-Marie Swain, APRN, and Nnenna A. Olubajo, APRN, permitted Swain and
Olubajo to unlawfully issue controlled substance prescriptions under Kolade’s name and
credentials while Kolade was engaged in overseas travel, in violation of 21 U.S.C. § 822(a)(2),

21 USC. § 823(f), 21 U.S.C. § 841 (a), 21 U

§ 842(a), 21 U.S.C. § 846, 21 CFR §
1306.03¢a)(1), 21 CFR § 1306.04(a), 21 CFR § 1306.05, NRS 453.226(1), NRS 453.232, NRS
453.321(1)(a), NRS 453.331(1) (f) and (h), NRS 453 381(1), NRS 453.401 (I)(a), NRS
639.100(1), NRS 639.235(1), NRS 639.281(1), NRS 639.2813(1) and/or NAC 453.440(1)(¢),
and is subject to discipline pursuant to NRS 453.236(1) and/or NRS 639.210(11) and/or (12);
B. Respondent was party to a fraudulent or deceitful practice or transaction,
performed his duties as the holder of controlled substance registration in an incompetent,

uunskillful or negligent manner, engaged in unprofessional conduct and conduct contrary to the


public interest in violation of NAC 639.945(1)(h) and (i), and is subject to discipline pursuant to
NRS 453.236(1) and NRS 639.210(4); and

C. Respondent has committed an act that would render his Nevada controlled
substance registration inconsistent with the public interest, and is subject to discipline pursuant to
NRS 453.236(1)(e) and NRS 453.241(1).

8. Those violations are plead with particularity in the Accusation, and are grounds
for action pursuant to NRS 453.236(1), NRS 453.241(1), NRS 639.210 and NRS 639.255.

9. In order to resolve this matter without incurring any further costs or the expense
associated with a hearing, the Board and Respondent stipulate to the following penalties. The
registration of Respondent Akindele E. Kolade, MD, Certificate of Registration No. CS21917, is
hereby suspended. The suspension is stayed, and Respondent is placed on probation for two (2)
years, subject to the following conditions:

A. Respondent shall accept this Stipulation and Order as a public reprimand
regarding his duties and responsibilities as a prescribing practitioner,

B, __ Respondent shall pay a fine of Five-Thousand Dollars ($5000.00) for the
violations, payable by cashier's check or certified check or money order made payable to “State
of Nevada, Office of the Treasurer,” to be received by the Board's Reno office located at 985,
Damonte Ranch Parkway ~ Suite 206, Reno, Nevada 89521, within thirty (30) days of the
effective date of this Order;

C. Respondent shall pay Two-Thousand Dollars ($2000.00) to partially
reimburse the Board for recoverable attorney's fees and costs incurred in investigating and
prosecuting this matter, payable by cashier's check or certified check or money order made
payable to “Nevada State Board of Pharmacy,” to be received by the Board’s Reno office located
at 985 Damonte Ranch Parkway — Suite 206, Reno, Nevada 89521, within thirty (30) days of the
effective date of this Order; and

D. Respondent shall comply with all federal and state statutes and regulations

regarding controlled substances and dangerous drugs, and have no new charges filed against him
by the Board while on probation.

10. Upon successful completion of probation, Respondent's Certificate of
Registration No CS21917 will be fully restored.

11. Any failure by Respondent to comply with the terms of this Order may result in
issuance by the Executive Secretary of an order to show cause pursuant to NAC 639.965
directing that Respondent to appear before the Board at the next regularly scheduled meeting for
a show cause hearing. If such a hearing results in a finding of a violation of this Order by
Respondent, the Board may impose additional discipline upon Respondent consistent with the
provisions of NRS Chapter 453 and/or Chapter 639

12. General Counsel will present this Stipulation to the Board for approval pursuant
to NRS 622.330 at the Board’s regularly scheduled public meeting on October 13, 2021.
Respondent will appear at the meeting to answer questions from the Board Members and/or
Board Staff. The Board Members and Staff may discuss and deliberate regarding this
Stipulation, even if Respondent 1s not present at the meeting

13. The Board has discretion to accept this Stipulation, but it is not obligated to do so.
If this Stipulation is approved by the Board, it shall be a public record pursuant to NRS 622.330.

14, If the Board rejects any part or all of this Stipulation, and unless they reach an
alternative agreement on the record during the hearing, the parties agree that a full hearing on the
merits of this matter may be heard by the Board. The terms and admissions herein may not be
used or referred to in a full hearing on the merits of this matter.

15. Subject to the approval of this Supulation by the Board, the Board and
Respondent agree to release each other from any and all additional claims arising from the facts
set forth in the Accusation on file herein, whether known or unknown that might otherwise have

existed on or before the effective date of this Order.

Respondent has fully considered the charges and allegations contained in the Notice of
Intended Action and Accusation wn this matter, and the terms of this Stipulation, and has

frecly and voluntarily agreed to the (erms set forth herein, and waived certain rights,
stated herein.
AGREED:
Lf
Signed this 1S"any of September, 2024 Signed cuist Oray of September, 2021
j
AKINDELE E. KOLADE. MD, BRETT RAMPT, ESQ.
Certificate of Registration No. CS21917 General Counsel

Nevada State Board of Pharmacy
APPRQYED AS TO FORM AND CON’
this/S“day of September, 2021

MARIA RYTILE, ESQ.
BRIDGET KELLY, ESQ.
Counsel for Respondent

DECISION AND ORDER
The Nevada State Board of Pharmacy hereby adopts the foregoing Stipulation as its
decision as to Akindele I: Kolade, MD, Certificate of Registration No CS21917, an Case No.
19-237-A-S and hereby orders that the terms of the foregomg Supulation be made effective upon
‘execution below
IT IS SO ORDERED.
Entered wis B® day of October. 2021

Zo

Helen Park, Pharm.D.
President
Nevada State Board of Pharmacy

CERTIFICATE OF SERVICE
I ceitify that 1 am an employee of the Nevada State Board of Pharmacy, and that on this
15 day of October, 2021, I served a true and correct copy of the foregoing document by Certified
USS. Mail to the following:
Bndget Kelly, Esq.
Notile Law

7395 S. Pecos Rd., Suite 103
Las Vegas, NV 89120

KRISTOPHER MANGOSING

